Neurology News and Research

Latest Neurology News and Research

Rapid sideline visual test effectively detects concussions in collegiate athletes

A sideline visual test effectively detected concussions in collegiate athletes, according to a team of researchers from the Perelman School of Medicine at the University of Pennsylvania.

2 Sep 2011

AAN calls all high school coaches, athletes and parents to learn signs of sports concussion

The American Academy of Neurology, the leading group of neurologists dedicated to managing sports concussion, is issuing a call to all youth and high school coaches, athletes and parents to learn the signs of sports concussion and to know when a player must leave the game.

2 Sep 2011

UTHealth Phase I trial: Bone marrow stem cell therapy feasible, safe for acute stroke patients

Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.

2 Sep 2011

Stroke hospitalization rates in adolescents and young adults increase up to 37%

Ischemic stroke hospitalization rates in adolescents and young adults aged 15 to 44 increased up to 37% between 1995 and 2008 according to a study conducted by researchers at the Centers for Disease Control and Prevention.

2 Sep 2011

Valproic acid may increase survival for brain tumor patients

New research suggests brain tumor patients who take the seizure drug valproic acid on top of standard treatment may live longer than people who take other kinds of epilepsy medications to control seizures.

2 Sep 2011

Older dads have a higher risk of having kids with mental disorders: Study

According to a new study children of older fathers have genetic changes associated with autism and other brain disorders. As of now this is seen only in lab mice. Professor John McGrath of the Queensland University’s Brain Institute and colleagues report their findings today in the journal Translational Psychiatry.

31 Aug 2011

Eisai announces results of perampanel Phase III study on epilepsy

Results presented today of a Phase III pivotal study for the investigational compound perampanel for partial-onset seizures showed that perampanel, 8 mg and 12 mg, produced statistically significant reductions in median seizure frequency compared to placebo among patients having partial-onset seizures while receiving treatment with one to three other epilepsy drugs.

31 Aug 2011

Gene variants can cut risk of Parkinson's disease

An international team of researchers led by neuroscientists at Mayo Clinic in Florida has found a genetic variation they say protects against Parkinson's disease. The gene variants cut the risk of developing the disease by nearly 20 percent in many populations.

31 Aug 2011

Age-related declines in hearing may accelerate brain atrophy

A new study by researchers from the Perelman School of Medicine at the University of Pennsylvania shows that declines in hearing ability may accelerate gray mater atrophy in auditory areas of the brain and increase the listening effort necessary for older adults to successfully comprehend speech.

31 Aug 2011

Valeant to acquire Afexa for C$76 million in cash

Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.

31 Aug 2011

Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe

Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.

30 Aug 2011

AAN calls on all neurology patients, caregivers to participate in 2012 Neuro Film Festival

The American Academy of Neurology Foundation is calling on all neurology patients and caregivers to submit a short video to its 2012 Neuro Film Festival, telling their story about why more research is needed into finding cures for brain disorders.

30 Aug 2011

Boehringer Ingelheim initiates two afatinib phase II studies in HER2-positive breast cancer

Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.

29 Aug 2011

One in three AF patients at high risk of stroke are not being prescribed VKA therapy

New data show that, worldwide, one in three patients with atrial fibrillation (AF) who are at high risk for stroke are not being prescribed anticoagulant therapy, particularly vitamin K antagonists (VKA) – medicines known to significantly lower stroke risk in these patients.

29 Aug 2011

CIRM approves stem cell research planning grants for five UC Davis teams

The California Institute for Regenerative Medicine (CIRM), the state stem cell agency, today approved research planning grants for five UC Davis Health System teams that are working to develop human clinical trials to treat illnesses such as Huntington's disease, vascular disease, osteoporosis, HIV/AIDS and airway disease in children.

29 Aug 2011

New ESC Guidelines on diagnosis and treatment of peripheral artery disease

For cardiologists, coronary artery disease is the most important presentation of atherosclerosis. Patients with coronary artery disease may also have symptomatic or asymptomatic atherosclerosis in other vascular areas (peripheral artery disease).

26 Aug 2011

IOM report: Few health problems are clearly associated with vaccines

An analysis of more than 1,000 research articles concluded that few health problems are caused by or clearly associated with vaccines.

26 Aug 2011

LWW receives 11 Apex Awards for Publication Excellence Competition

Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, is pleased to announce that seven LWW published journals have won 11 highly regarded awards in this year's Apex Awards for Publication Excellence Competition, recognizing publishing excellence in a variety of categories. Emergency Medicine News took home the esteemed Grand Award for Excellence in the category of 'Magapapers & Newspapers.'

26 Aug 2011

DaTscan allows doctors to differentiate Parkinson's from other movement disorders

Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.

26 Aug 2011

Allergan gets FDA nod for use of Botox in urinary incontinence

Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.

25 Aug 2011

Neurology News and Research

Latest Neurology News and Research

Rapid sideline visual test effectively detects concussions in collegiate athletes

AAN calls all high school coaches, athletes and parents to learn signs of sports concussion

UTHealth Phase I trial: Bone marrow stem cell therapy feasible, safe for acute stroke patients

Stroke hospitalization rates in adolescents and young adults increase up to 37%

Valproic acid may increase survival for brain tumor patients

Older dads have a higher risk of having kids with mental disorders: Study

Eisai announces results of perampanel Phase III study on epilepsy

Gene variants can cut risk of Parkinson's disease

Age-related declines in hearing may accelerate brain atrophy

Valeant to acquire Afexa for C$76 million in cash

Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe

AAN calls on all neurology patients, caregivers to participate in 2012 Neuro Film Festival

Boehringer Ingelheim initiates two afatinib phase II studies in HER2-positive breast cancer

One in three AF patients at high risk of stroke are not being prescribed VKA therapy

CIRM approves stem cell research planning grants for five UC Davis teams

New ESC Guidelines on diagnosis and treatment of peripheral artery disease

IOM report: Few health problems are clearly associated with vaccines

LWW receives 11 Apex Awards for Publication Excellence Competition

DaTscan allows doctors to differentiate Parkinson's from other movement disorders

Allergan gets FDA nod for use of Botox in urinary incontinence

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Neurology News and Research

Latest Neurology News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in